[
  {
    "ts": "2025-11-03T21:09:00+00:00",
    "headline": "Quest Diagnostics to Speak at Citi's 2025 Global Healthcare Conference",
    "summary": "Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President and Chief Financial Officer, will speak on the company's strategy, performance and the latest market developments and trends during Citi's 2025 Global Healthcare Conference in Miami on Tuesday, December 2, 2025, at 3:15 p.m. Eastern Time.",
    "url": "https://finance.yahoo.com/news/quest-diagnostics-speak-citis-2025-210900828.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "9d6f68b5-316f-3b7a-bee7-7b9bfcf614e6",
      "content": {
        "id": "9d6f68b5-316f-3b7a-bee7-7b9bfcf614e6",
        "contentType": "STORY",
        "title": "Quest Diagnostics to Speak at Citi's 2025 Global Healthcare Conference",
        "description": "",
        "summary": "Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President and Chief Financial Officer, will speak on the company's strategy, performance and the latest market developments and trends during Citi's 2025 Global Healthcare Conference in Miami on Tuesday, December 2, 2025, at 3:15 p.m. Eastern Time.",
        "pubDate": "2025-11-03T21:09:00Z",
        "displayTime": "2025-11-03T21:09:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/596f9c53c019a633fa68d8b76e9b4722",
          "originalWidth": 400,
          "originalHeight": 190,
          "caption": "questhealth.com logo (PRNewsfoto/Quest Diagnostics)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/v6s3D2c6OzmZrj.0kIY12Q--~B/aD0xOTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/596f9c53c019a633fa68d8b76e9b4722.cf.webp",
              "width": 400,
              "height": 190,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AFrizODjj_bBgmzRgIgaqw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/596f9c53c019a633fa68d8b76e9b4722.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-speak-citis-2025-210900828.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-speak-citis-2025-210900828.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-03T08:14:21+00:00",
    "headline": "Quest Diagnostics (DGX): Assessing Valuation After Recent Steady Share Price Performance",
    "summary": "Quest Diagnostics (DGX) stock climbed slightly today, gaining just above 0% after a relatively quiet session. Investors seem to be weighing recent performance, as shares are up 17% year-to-date and have outperformed over the past year. See our latest analysis for Quest Diagnostics. Quest Diagnostics has kept a steady pace in 2024, with a year-to-date share price return of 16.55% building on persistent gains seen over the past year. Notably, the company’s 1-year total shareholder return of...",
    "url": "https://finance.yahoo.com/news/quest-diagnostics-dgx-assessing-valuation-081421852.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "5903749d-f436-385a-96f1-b45c3deeee00",
      "content": {
        "id": "5903749d-f436-385a-96f1-b45c3deeee00",
        "contentType": "STORY",
        "title": "Quest Diagnostics (DGX): Assessing Valuation After Recent Steady Share Price Performance",
        "description": "",
        "summary": "Quest Diagnostics (DGX) stock climbed slightly today, gaining just above 0% after a relatively quiet session. Investors seem to be weighing recent performance, as shares are up 17% year-to-date and have outperformed over the past year. See our latest analysis for Quest Diagnostics. Quest Diagnostics has kept a steady pace in 2024, with a year-to-date share price return of 16.55% building on persistent gains seen over the past year. Notably, the company’s 1-year total shareholder return of...",
        "pubDate": "2025-11-03T08:14:21Z",
        "displayTime": "2025-11-03T08:14:21Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pUPV1p_Bw8ydOCyP5dgMaw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SLvgYYeIn3Dw6STv9CZZCg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-dgx-assessing-valuation-081421852.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-dgx-assessing-valuation-081421852.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]